14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $141.16 $183.01 Monday, 6th May 2024 CCCC stock ended at $6.71. This is 0.445% less than the trading day before Friday, 3rd May 2024. During the day the stock fluctuated 6.60% from a day low at $6.44 to a day high of $6.86.
90 days $141.16 $227.30
52 weeks $84.73 $227.30

Historical C4 Therapeutics Inc prices

Date Open High Low Close Volume
May 06, 2024 $6.83 $6.86 $6.44 $6.71 1 182 526
May 03, 2024 $6.70 $6.94 $6.57 $6.74 916 513
May 02, 2024 $6.57 $6.63 $6.28 $6.43 980 979
May 01, 2024 $6.34 $6.61 $6.22 $6.54 1 782 770
Apr 30, 2024 $6.22 $6.38 $6.17 $6.30 903 050
Apr 29, 2024 $6.23 $6.44 $6.19 $6.32 1 063 629
Apr 26, 2024 $6.30 $6.37 $6.12 $6.17 1 046 912
Apr 25, 2024 $6.30 $6.34 $6.15 $6.24 1 417 958
Apr 24, 2024 $6.91 $6.99 $6.46 $6.47 1 038 945
Apr 23, 2024 $6.92 $7.15 $6.89 $6.90 911 554
Apr 22, 2024 $6.82 $7.00 $6.71 $6.86 711 718
Apr 19, 2024 $6.86 $7.16 $6.53 $6.72 1 704 655
Apr 18, 2024 $6.95 $7.06 $6.76 $6.91 1 119 217
Apr 17, 2024 $6.86 $7.01 $6.75 $6.87 1 156 424
Apr 16, 2024 $6.70 $6.93 $6.62 $6.83 1 232 297
Apr 15, 2024 $7.36 $7.38 $6.78 $6.86 1 915 542
Apr 12, 2024 $7.89 $8.08 $7.36 $7.41 1 848 159
Apr 11, 2024 $7.80 $7.92 $7.53 $7.79 862 300
Apr 10, 2024 $7.48 $7.81 $7.41 $7.72 1 389 008
Apr 09, 2024 $7.65 $7.99 $7.61 $7.97 1 141 426
Apr 08, 2024 $7.56 $7.80 $7.34 $7.66 1 029 312
Apr 05, 2024 $7.68 $7.91 $7.51 $7.52 1 219 181
Apr 04, 2024 $7.97 $8.07 $7.70 $7.72 1 507 196
Apr 03, 2024 $7.64 $7.90 $7.44 $7.90 1 198 843
Apr 02, 2024 $7.80 $7.93 $7.56 $7.68 1 272 973
Click to get the best stock tips daily for free!

About C4 Therapeutics Inc

C4 Therapeutics C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidate is CFT7455, an orally bioavailable MonoDAC degrader of protein that is in Phase 1/2 trial targeting IKZF1 and IKZF3 for multiple myeloma and non-Hodgkin lymphomas, including peripheral T-cell lymphoma an... CCCC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT